Is the Turnaround at GameStop Sustainable After 2020?
Has video game retailer GameStop broken out of the downward spiral that had captured it for so long? Two analysts are optimistic about the company's near-term outlook.
All Work
Chris Lange
Caledonia Rolls the Dice on Scientific Games With Massive Stake
Scientific Games was one of Monday’s big winners after the company announced that it had reached an agreement with a credentialed gaming industry investor to buy a significant stake in the company.
Corsair Gaming Announces Potential Pricing for IPO
High-performance gear provider Corsair Gaming intends to price 14 million shares to result in an initial public offering valued up to nearly $290 million.
Are Immunomedics Shareholders Getting Enough in the Acquisition?
Immunomedics shares more than doubled on Monday after the firm announced that it would be acquired by Gilead Sciences in one of the biggest deals to go down in the health care sector this…
What Analysts Are Saying About Lululemon After Earnings
Though Lululemon Athletica topped estimates when it posted its fiscal second-quarter results this week, investors ultimately sent shares lower. Yet, analysts remain fairly positive on the stock.
Short Sellers Hike Their Bets in Major Biotechs
The August 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Short Sellers Yield on Semiconductors, With One Major Exception
The August 31 short interest data have been compared with the previous report, and short sellers backed off from most of these selected semiconductor stocks, with one major exception.
Peloton Races Ahead With Q4 Results
Peloton Interactive Inc. (NASDAQ: PTON) released its fiscal fourth-quarter earnings report before the opening bell Tuesday. The firm said that it had $0.27 in earnings per share (EPS) and $607.1 million in revenue, which…
Oracle Rides to More Multiyear Highs After Q1 Results
Oracle reported fiscal first-quarter earnings per share of $0.93 and $9.37 billion in revenue after markets closed Thursday. Results beat both top- and bottom-line estimates.
Bed Bath & Beyond Added to Best Ideas List and Could Be Turning Around Soon
Bed Bath & Beyond stock has been beaten up so far this year, but one analyst thinks that it has the potential to rally.
This Late-Stage Study Is Giving Satsuma Pharma Stock Migraines
After Satsuma Pharmaceuticals reported disappointing late-stage results from its migraine treatment, and its shares were absolutely crushed Thursday morning.
Innoviva Wins Another Key FDA Approval for Asthma
The FDA has approved Innoviva's treatment of asthma and for patients with chronic obstructive pulmonary disease, the company announced, giving shares a boost early Thursday.
5 Very Undervalued Large Cap Biotech Stocks That Could Explode in 2021
Practically any biotech company attempting almost anything COVID-19 related has seen massive gains. However, there is likely more to come for the rest of the year and into next year. These five stocks could…
Should Zscaler Get More Credit For Its Q4 Results?
Cloud computing company Zscaler released its fiscal fourth-quarter financial results after markets closed on Wednesday. The firm reported $0.05 in earnings per share (EPS) and $125.9 million in revenue, beating analysts' consensus estimate on…
GameStop Is Still In Trouble Despite Incredible E-Commerce Growth
GameStop posted a fiscal second-quarter net loss per share of $1.40 on $942.0 million in revenue. The consensus estimates had called for a net loss of $1.13 per share and $1.02 billion in revenue.
Academy Sports and Outdoors Plans to Come Public in Massive IPO
Sporting goods and outdoor recreational equipment retailer Academy Sports and Outdoors has filed for an initial public offering.
iBio Takes Another Big Step in the Fight Against COVID-19
iBio has announced that it has selected a vaccine to advance for the prevention of infection by the coronavirus that causes COVID-19.
Intra-Cellular Therapies Finds Euphoria in Bipolar Study Results
Intra-Cellular Therapies was one of the biggest winners on Wednesday after the company announced positive results from its late-stage clinical trial in patients with bipolar disorder.
StepStone Closes In on IPO With Potential Pricing
Investment firm StepStone intends to price more than 17 million shares to result in an initial public offering valued up to more than $342 million.
Why This FDA Update Is a Huge Step Forward for Precision BioSciences
A key update from the FDA on its treatment for relapsed/refractory multiple myeloma boosted Precision BioSciences shares early on Wednesday.